Product logins

Find logins to all Clarivate products below.


Heart Valve Devices | Market Insights | Europe (Supplemental) | 2023

The global COVID-19 pandemic negatively impacted the European heart valve device market to some extent. However, in the longer term, the market will be driven by positive results from THV device clinical trials, new product launches, and the rapid adoption of THV devices, resulting in moderate growth through 2031.

This Medtech 360 Report provides high-level market metrics for heart valve devices in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2031.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…
Report
Diagnostic Imaging Systems – Market Insights – Europe
The diagnostic imaging system market in Europe is expected to experience gradual growth through 2034, supported by the continued rollout of advanced technologies, rising adoption of AI-driven…
Report
Aesthetic Injectables – Market Insights – Europe
The European aesthetic injectable market is on a strong growth trajectory. Product innovation and differentiated offerings from leading companies are expected to propel this expansion. The…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2034, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…